Naloxone treatment alters gene expression in the mesolimbic reward system in 'junk food' exposed offspring in a sex-specific manner but does not affect food preferences in adulthood Physiology and Behavior, 2014; 133:14-21 
Introduction 66
The increased consumption of junk foods is a major contributing factor to the rise in obesity 67 prevalence [1, 2] . The term 'junk food' can be used to describe any food that is high in fat, 68 sugar and salt, low in protein and otherwise energy dense and nutrient poor [3] . The ready 69 availability of 'junk foods' in modern society makes it important to understand why some 70 people have a greater tendency to over-consume these types of food than others. In this 71 context, it is significant that data from both human and animal studies have shown that food 72 preferences can be established very early in life, and that excessive maternal intake of junk 73 foods during pregnancy and lactation is associated with an increased preference for fat and 74 sugar in juvenile and adult offspring [4, 5] . 75
More recently, attempts have been made to understand the mechanisms which contribute to 76 the programming of food preferences, with a particular focus on the impact of perinatal 'junk 77 food' exposure on the mesolimbic reward system. We and others have demonstrated that 78 maternal consumption of high-fat and/or cafeteria diets during pregnancy and lactation 79 induces permanent alterations in the structure and function of this system in juvenile and adult 80 offspring [4, 6, 7] . We have previously shown that the mRNA expression of the mu-opioid 81 receptor in the central reward pathway at weaning is reduced by perinatal exposure to a 'junk 82 food' diet, and that this was associated with a reduced sensitivity to the effect of the opioid 83 antagonist, naloxone, in reducing fat intake after weaning [8] . These findings led us to 84 hypothesize that the opioid signaling pathway plays a critical role in the early programming of 85 food preferences, and that exposure to excess endogenous opioids during the perinatal period 86 as a result of maternal junk food consumption [9, 10] alters the development of the opioid 87 signaling pathway in the offspring, resulting in persistent effects on the function of the reward 88 system. 89
In the current study, we sought to extend our previous findings by investigating the impact of 90 naloxone administration for a 10 day period after weaning on gene expression of key 91 components of the mesolimbic reward pathway. Specifically, we aimed to determine the 92 effect opioid receptor blockade on the mRNA expression of mu-opioid receptor and the 93 endogenous opioid proenkephalin as well as elements of the dopamine pathway including 94 tyrosine hydroxlase (TH), dopamine receptors 1 and 2 and the dopamine active transporter 95 (DAT), all of which have been previously implicated in the regulation of palatable food 96 intake [11] [12] [13] [14] [15] [16] [17] . We hypothesized that opioid receptor blockade would ameliorate the changes 97 in gene expression in the dopamine and opioid pathways we have previously reported in 98 offspring exposed to cafeteria diets during the perinatal period [4, 8] . We also aimed to 99 investigate the hypothesis that opioid antagonist treatment in the immediate post-weaning 100 period would have persistent effects on food preferences in the adult offspring, independent of 101 perinatal dietary exposure. 102
Methods 103

Animals and feeding 104
This study was approved by the Animal Ethics committee of the University of Adelaide. 105
Details of the experimental procedure have been published previously [8] . Briefly, 37 female 106 and 4 male Albino Wistar rats were allowed to acclimatize to animal housing facility for at 107 least 1 week before the commencement of the dietary intervention. Female rats were divided 108 into either the control (C, n=18) or junk food (JF, n=19) group, such that the average weight 109 of the animals at the start of the experiment was not different between treatments. The C 110 group received a standard rodent feed (Specialty Feeds, Glen Forrest, WA, Australia), while 111 the JF group received a cafeteria diet that included peanut butter, hazelnut spread, savory 112 snacks, chocolate biscuits, sweetened cereal and a lard and chow mix. Detailed nutritional 113 information on this diet has been published previously [4] . The female rats were provided 114 with their respective diets for two weeks prior to mating and throughout pregnancy and 115
lactation. 116
Females were mated with one of 4 proven males (the same males were used for both groups), 117 that were maintained on a standard rodent feed. Pups were born on day 21-22 of gestation and 118 litters were culled to 8 pups (4 male, 4 female where possible) 24 hours after birth. Pups were 119 housed with their mothers and weighed every second day until weaning at postnatal day 21. 120
The offspring of C and JF dams are referred as C and JF offspring respectively. 121
Naloxone treatment 122
At weaning, pups were either killed for gene expression analysis or housed with a same sex 123 littermate and administered the opioid antagonist naloxone or saline (vehicle). Details of this 124 procedure have been published previously [8] . Briefly, pups were randomly assigned to 125 receive daily intraperitoneal injection of either naloxone, (5mg/kg, naloxone hydrochloride 126 dihydrate, Sigma Aldrich, St Louis, MO USA) or an equivalent volume of saline (vehicle) 30 127 minutes before the onset of the dark cycle for 10 days. Naloxone at this dose has been 128 previously reported to acutely suppress food intake in pre-weaning rat pups [18] and we 129 confirmed in a pilot dose-response study that this dose was the most effective in reducing 130 intake of the cafeteria diet in the immediate post-injection period, without any adverse effects 131 on pup growth/development. All rats were weighed immediately prior to injection to ensure 132 accurate dosage. All offspring were given free access to both the control and cafeteria diet 133 throughout the injection period to allow the determination of food preferences (results 134 previously published [8] ). This generated four groups of offspring, offspring of C dams given 135 saline (C-C, n=15 male, 16 female), offspring of C dams given naloxone (C-N, n=16 male, 16 136 female), offspring of JF dams given saline (JF-C, n=18 male, 14 female) and offspring of JF 137 dams give naloxone (JF-N, n=17 male, 14 female). 138
Determination of gene expression in the NAc and VTA at 3 weeks 139
Pups not designated to receive the naloxone/saline treatment were killed at weaning and the 140 whole brain was removed (C, n=10 male, 8 female and JF, n=9 male, 8 female). The nucleus 141 accumbens including both shell and core regions (NAc) and the ventral tegmental area 142 (VTA) were isolated and stored as described previously [4] . Total mRNA was extracted using 143
Trizol reagent (Invitrogen Australia, Mount Waverley, Vic, Australia), purified using an 144 RNeasy Mini kit (Qiagen Australia, Doncaster, Vic, Australia) and cDNA synthesized using 145 Superscript III reverse transcriptase (Invitrogen Australia) and random hexamers. Foster City, CA, USA). Target genes were the same as at 3 weeks with the addition of the 164 endogenous opioid proenkephalin. The primer sequences have been previously published [4, 165 19] and the proenkephalin primers were validated for use in our laboratory prior to beginning 166 the experiment. The expression of target genes was quantified relative to three housekeeper 167 genes: β-actin, cyclophilin and GAPDH, using the Applied Biosystems Data Assist software 168 (Applied biosystems, Foster City, CA, USA). This software allows expression of each target 169 gene to be measured against the mean normalized expression of the three housekeepers. Two 170 quality controls as well as a negative RT control were used on each 384-well plate to ensure 171 inter-plate consistency and melt curves were obtained at the end of each run. 172
Determination of food preferences 173
Following naloxone/saline treatment, remaining offspring (not used in gene expression 174 analysis) were placed on the standard rodent feed until 10 weeks of age. Offspring (C-C, n= 7 175 male, 8 female; C-N, n=8 male, 8 female; JF-C, n= 9 male, 6 female; JF-N, n=8 male, 6 176 female) were then given access to the both the standard rodent feed and the cafeteria diet for a 177 further two weeks until 12 weeks age. The amount of standard rodent feed and each 178 component of the cafeteria diet consumed were assessed every two days and macronutrient 179 preference calculated based on the nutritional composition of each food type. Body weight of 180 the offspring was recorded weekly from weaning. 181
Postmortem 182
At 3 weeks, 3 weeks +10 days and 12 weeks of age, one male and one female pup from each 183 litter was killed for the determination of body fat mass. The rats were not fasted prior to 184 postmortem and all postmortems were conducted in light phase between 8-10 AM. All 185 animals were weighed immediately prior to being killed with an overdose of CO 2 . All internal 186 organs were weighed and individual fat depots including retroperitoneal fat, omental fat, 187 gonadal fat, interscapular fat and subcutaneous fat were isolated to determine the weight of 188 each depot as well as total fat mass. All fat depots were snap frozen in liquid nitrogen and 189 stored at -80°C for future molecular analyses. Blood samples were collected by cardiac 190 puncture into heparinized tubes, and blood was centrifuged at 3,500g, 4˚C for 15 minutes and 191 plasma stored at -20˚C for subsequent analysis of hormone and metabolite concentrations. 192
Determination of hormone and metabolite concentrations 193
Plasma concentrations of glucose and non-esterified fatty acids (NEFA) were analysed using 194 the Infinity Glucose Hexokinase kit (Thermo Electron, Pittsburgh, PA, USA) and the Wako 195 NEFA C kit (Wako Pure Chemical Industries Ltd, Osaka, Japan), respectively. Assays were 196 performed using Konelab 20 (Thermo Scientific, Vantaa, Finland). Plasma leptin and insulin 197 concentrations were measured by immunoassay using the Crystal Chem Rat Leptin ELISA kit 198 (Crystal Chem Inc, Downers Grove, IL, USA) and the ALPCO Insulin (Rat) Ultrasensitive 199 ELISA kit (ALPCO Diagnostics, Salem, NH, USA). All assays were conducted in accordance 200 with manufacturer's instructions and intra-and inter-assay coefficients of variation were 201 <10%. 202
Statistical Analysis 203
Analysis of gene expression, plasma hormones, food preference and fat mass was conducted 204 using a two-way ANOVA with maternal diet and naloxone/saline treatment as factors. The 205 two-way ANOVA was performed using SPSS statistics 18.0 software (SPSS Inc., Chicago, 206 IL, USA). Offspring body weight gain and food intake over time was analysed by two-way 207 repeated measures ANOVA, which was performed on Stata 11 software (StataCorp., TX, 208 USA). Male and female offspring were analysed separately for all measures to provide clarity 209 in presentation, as three-way ANOVA analysis using sex as an additional factor revealed a 210 significant interaction between sex and treatment for the majority of outcomes measured. All 211 data are presented as mean±SEM with a P value of <0.05 considered statistically significant. 212
Results 213
Effect of maternal diet on birth outcomes 214
Birth outcomes including birth weight of these offspring has been previously published [8] . 
Effect of maternal diet on target gene expression in the VTA and NAc at weaning 221
As published previously, mRNA expression of the mu-opioid receptor at weaning was lower 222 in the VTA of both male and female JF offspring, and higher in the NAc of male, but not 223 female, JF offspring compared to C offspring [8] . There was no effect of perinatal diet 224 exposure on DAT expression in the VTA (Table 1) , whilst in the NAc DAT expression was 225 lower in the offspring of JF dams compared to controls in both males and females (P<0.05, 226 Table 1 ). There was no difference in the mRNA expression of TH or the D1 and D2 dopamine 227 receptors in either brain region between the control and JF offspring in either males or 228 females ( Table 1) . 229 
Effect of naloxone treatment on target gene expression in the VTA and NAc in control and 231
JF offspring 232
Mu-opioid receptor and proenkephalin 233
There was no effect of naloxone treatment on mu-opioid receptor expression in the VTA of 234 either male or female C or JF offspring (Fig. 1A) . The mRNA expression of the mu-opioid 235 receptor in the NAc was higher in male JF offspring compared to controls (P<0.05), and also 236 tended (P=0.07) to be higher in female JF offspring, independent of whether they received 237 naloxone or saline ( Fig. 1B) . 238
The effect of naloxone treatment during the post-weaning period on mRNA expression of the 239 endogenous opioid, proenkephalin, in the VTA of male offspring was influenced by perinatal 240 diet, such that mRNA expression was reduced by naloxone treatment only in those offspring 241 exposed to a JF diet before weaning (P<0.05, Fig 1C) . There was no effect of either perinatal 242 diet or naloxone treatment on proenkephalin mRNA expression in the NAc of male offspring 243 (Fig. 1C ). In females, there was no effect of either naloxone treatment or perinatal diet on 244 proenkephalin mRNA expression in the VTA. Proenkephalin expression in the NAc, 245 however, was significantly higher in female JF offspring compared to control offspring 246 independent of naloxone treatment (P<0.05, Fig. 1D ). 247
DAT, TH and the D1 and D2 dopamine receptors 248
In female offspring, the effects of naloxone treatment on DAT expression in both the VTA 249
and NAc was dependent on perinatal dietary exposure; such that DAT expression was 250 decreased by naloxone treatment in C offspring but increased by naloxone treatment in JF 251 offspring in both brain regions (P<0.05, Fig. 1E, F) . In male offspring, naloxone treatment 252 decreased DAT expression in the NAc of both C and JF offspring (P<0.05, Fig. 1F ), but there 253 was no effect of either perinatal dietary exposure or naloxone treatment on DAT mRNA 254 expression in the VTA (Fig. 1E) . 
F. E.
There was no effect of either perinatal diet or naloxone treatment on TH, D1 or D2 mRNA 264 expression in male offspring in either the NAc or VTA. In contrast, TH and D2 mRNA 265 expression was decreased in the VTA of female JF offspring compared to C offspring, 266 independent of naloxone treatment (Table 2 ). Naloxone treatment also reduced D1 receptor 267 expression in the VTA, but not NAc, of female JF offspring. In contrast D1 and D2 receptor 268 expression in the NAc was decreased by naloxone treatment in C offspring (Table 2) . 269
Effect of maternal diet and naloxone on plasma hormone and metabolite concentrations at 270 3 weeks +10 days 271
There was no effect of either perinatal diet or naloxone treatment on plasma concentrations of 272 glucose, NEFA, insulin or leptin at 10 days postweaning in either male or female offspring 273 (Table 3) . 274
Effect of maternal diet and naloxone treatment on offspring growth and food intake 275
From weaning (day 21) until 12 weeks of age (day 90) both male (P<0.05, Fig. 2A ) and 276 female (P<0.05, Fig. 2B ) JF offspring were significantly lighter than C offspring. There was 277 no effect of naloxone treatment on body weight at any time point during the experiment in 278 either C or JF offspring 279
As previously reported, during the 10 day naloxone treatment post-weaning, when all 280 offspring had free access to both the cafeteria diet and standard laboratory chow female, but 281 not male, JF offspring consumed more fat and energy than their control counterparts [8] . 282
From the end of the 10 day naloxone treatment (3weeks + 10 days of age) until 10 weeks of 283 age all offspring were fed standard laboratory chow. For the first 4 weeks on the chow diet 284 both male and female offspring of JF dams had significantly higher food intake than C 285 offspring independent of whether they had been treated with saline or naloxone (P<0.05, Fig,  286   4A,B ). An interaction was present between perinatal diet and postnatal week, such that the 287 difference in food intake between C and JF offspring decreased with increasing postnatal age. 288
In male offspring only, there were no longer any significant differences in food intake 289 between C and JF offspring by the fifth week on the chow diet (10 postnatal weeks) (Fig. 3A) . 290
Chow intake in female offspring remained significantly higher than C offspring throughout 291 this period (P<0.05, Fig. 3B) . Table 3 . Plasma concentrations of glucose, NEFA, insulin and leptin in male and female offspring of C and JF dams treated with either saline or naloxone at 3wk+10days
Values expressed as mean±SEM, n= 8-9 for all groups. A. 
Effect of maternal diet and naloxone treatment on offspring food preference and body 310 composition 311
When all offspring were provided with free access to both the control and cafeteria diet for 312 two weeks from 10-12 weeks of age, there was no difference in food intake between groups in 313 either males or females. Thus, neither perinatal diet nor naloxone treatment had any effect on 314 the intake of fat, carbohydrate, protein or total energy during this period (Table 4 ). There was 315 also no difference between groups in the intake of any individual component of the cafeteria 316 diet or the control diet in either males or females (data not shown). 317
At 12 weeks of age, there was no significant differences in the percentage of total body fat 318 mass between C and JF offspring nor any effect of naloxone treatment in either males (C-C 319 16.5±0.95%, C-N 16.0±0.64%, JF-C 14.2±0.72%, JF-N 14.8±0.57%) or females (C-C 320 19.3±0.10%, C-N 19.0±0.78%, JF-C 18.5±0.13%, JF-N 18.7±0.15%). 321 322 Table 4 . Average daily macronutrient intake of control and junk food offspring treated with either saline or naloxone, when given access to both the control and JF diet from 10-12 weeks of age Values expressed as mean±SEM, n= 6-8 for all groups.
Discussion 324
This study has shown that administration of the opioid antagonist naloxone for 10 days after 325 weaning alters the gene expression of key components of the opioid and dopamine signaling 326 pathways in the mesolimbic reward system in a sex-specific manner. Importantly, the effects 327 of naloxone treatment on a number of these genes were dependent on whether pups had been 328 exposed to a cafeteria ('junk food') diet during the perinatal period. The differences in gene 329 expression at the end of the period of naloxone treatment were not, however, associated with 330 altered food preferences in adulthood in either C or JF offspring. Thus, perinatal junk food 331 exposure alters the short-term response of the reward pathway to opioid receptor blockade in 332 the immediate post-weaning period, but opioid receptor blockade during this time does not 333 appear to cause persistent alterations in food preferences, independent of the perinatal diet. In the present study, we found no difference in expression of the mu-opioid receptor in the 337 VTA between C and JF offspring at 10 days after weaning, independent of whether the 338 offspring had been treated with naloxone or saline during this period. This is different to the 339 situation at weaning, at which time mu-opioid receptor expression in the VTA is lower in JF 340 offspring than controls [8]. In interpreting these findings, it is important to note that all 341 offspring, independent of their perinatal nutrition, were provided with free access to the 342 cafeteria diet during the 10 day period of naloxone/saline treatment. One possible explanation, 343 therefore, is that a 10 day period of junk food exposure after weaning was sufficient to induce 344 a down-regulation of mu-opioid receptor expression to the same level as in offspring who 345 were also exposed to junk food during the perinatal period. In males, mu-opioid receptor 346 expression in the NAc was increased in JF offspring both at weaning [8] and after the 10 day 347 naloxone/saline treatment. Increases in expression of the mu-opioid receptor in the NAc have 348 also been observed in the adult offspring of JF-fed dams, suggesting that this is a persistent 349 consequence of perinatal exposure to a palatable diet [6] . These results also highlight that the 350 response to perinatal dietary exposures varies between specific brain regions. It is possible 351 that the increased mu-opioid expression in the NAc is a result of chronic exposure to the 352 cafeteria diet during the development of the reward pathway, since chronic sugar 353 consumption has been previously reported to increase mu-opioid receptor expression in this 354 brain region in adult rats [20] . 355
Interestingly, we found no effect of naloxone treatment on mu-opioid expression in either the 356 NAc or VTA. This was unexpected given that naloxone treatment in rodents prior to weaning 357 has previously been shown to increase mu-opioid receptor levels in the striatum [21, 22] . 358
However, in these prior studies naloxone treatment was given from birth and receptor levels 359
were measured using radio-labelled binding analysis which may have contributed to the 360 incongruent results. It is also possible, however, that the availability of the cafeteria diet 361 during the period of naloxone exposure, and the associated stimulation of endogenous opioid 362 production, was sufficient to counteract the effect of opioid receptor blockade, thus resulting 363 in a maintenance of receptor expression. 364
While there were no differences in the expression of the mu-opioid receptor in the NAc 365 between control and JF offspring in females, mRNA expression of the endogenous opioid, 366 proenkephalin, was increased in this brain region in female JF offspring, but was not affected 367 by naloxone treatment. This is consistent with previous studies in which exposure to a high-368
fat and/or high-sugar diet was reported to increase the release of endogenous opioids [9, 10] . 369
It is possible that the higher proenkephalin expression in female JF offspring was a 370 consequence of their higher fat intake in the 10 days post-weaning, since previous studies 371 have reported positive associations between proenkephalin expression and fat consumption in 372 adult rodents [23] . In male offspring, proenkephalin mRNA expression was reduced by 373 naloxone treatment in offspring of JF dams, but not in offspring of control dams. Given that 374 opioid receptor blockade is typically associated with a compensatory up regulation of 375 endogenous opioids [24] , this result suggests that perinatal junk food exposure alters the 376 subsequent response of the reward pathway to opioid receptor blockade, indicating a potential 377 dysregulation of opioid signaling in these offspring. consistent with previous studies in our laboratory, in which DAT mRNA expression at 6 386 weeks of age was reduced in offspring exposed to a junk food diet during the perinatal period 387
[4]. Since DAT is primarily responsible for the reuptake of dopamine from the synapse, and 388 therefore terminating the dopamine signal, the lower DAT mRNA expression would be 389 expected to result in increased dopamine signaling in the JF group. Interestingly, there were 390 no longer any differences in DAT mRNA expression between the control and JF offspring at 391 the end of the 10 day period of naloxone/saline treatment. Again, it is possible that exposure 392 of the control offspring to junk food during this period could have resulted in reduced DAT 393 mRNA expression. Interestingly, we saw no effect of either naloxone treatment or perinatal 394 junk food exposure on DAT expression in the VTA, which is considered to be the main site of 395 DAT activity [25, 26] , however the significance of this finding remains unclear. 396
We found that naloxone treatment reduced expression of DAT in the NAc of male offspring 397 and in the VTA and NAc of female control offspring. Opioid receptor blockade has 398 previously been shown to lower extracellular dopamine concentrations [27, 28] , which may 399 have elicited a compensatory downregulation of DAT in order to maintain dopamine 400 signaling. Given that the naloxone treatment was applied at a time when the reward pathway 401 is still undergoing development, and that dopamine plays an important role in the ontogenic 402 increase in DAT mRNA expression, an alternate explanation may be that naloxone treatment 403 inhibited this normal developmental process [29, 30] . Interestingly, in female JF offspring 404 naloxone treatment increased DAT expression in both the VTA and NAc. This unexpected 405 response to opioid receptor blockade may suggest a dysregulation of the reward pathway in 406 these animals as a result of early life exposure to a junk food diet. 407
In female offspring, but not in males, the expression of TH, D1 and D2 receptor mRNA was 408 decreased by naloxone treatment in offspring exposed to the junk food diet during the 409 perinatal period. Decreases in the expression of elements of the dopamine pathway have been 410 previously associated with chronic cafeteria diet consumption [31, 32], whilst opioid 411 antagonism has been shown to reduce extracellular dopamine levels [27, 33] . Different 412 responses to exogenous opioids between sexes has also been widely reported in adults [34, 413 35] and may be due to differences in levels of gonadal hormones between males and females, 414 as estrogen is known to contribute to the regulation of the endogenous opioid system [36] . 415
Maternal JF consumption increases offspring chow intake during the juvenile period but 416
did not affect palatable food intake in adult hood 417
In the present study both male and female JF offspring exhibited an increased intake of 418 standard rodent feed throughout the juvenile period (6-9 weeks) compared to controls. This 419 hyperphagia was most marked immediately after weaning, and became less pronounced with 420 increasing postnatal age. The presence of hyperphagia in offspring exposed to an increased 421 supply of fat and/or sugar during the perinatal period has been widely reported in previous 422 studies [37, 38] , and is thought to be a consequence of programming of the central appetite 423 regulating circuits [19] . 424
However, contrary to our hypothesis, we found no effect of opioid receptor blockade post-425 weaning on food preferences in adulthood, independent of perinatal junk food exposure. Since 426 the development of the reward circuitry extends into the fourth postnatal week in rodents [39, 427 40], one explanation for the lack of effect observed may be that the junk food exposure after 428 weaning was sufficient to program an increased preference for fat in adult control offspring 429 equivalent to that induced by exposure to the cafeteria diet for the entire perinatal period. This 430 is supported by data from a previous study, in which mice exposed to a palatable diet only 431 during the fourth week of life were found to exhibit a greater preference for palatable foods as 432 adults when compared to animals who had never been exposed to the palatable diet [41] . 433
Furthermore, in our study, naloxone treatment was only administered at concentrations 434 (5mg/kg) capable of reducing food intake for two hours post injection [42, 43] . The acute 435 nature of the treatment may have limited any long term effects, since a previous study has 436
identified changes in feeding behavior in juvenile rats which were treated with the opioid 437 antagonist naltrexone (which is capable of reducing food intake for 6hrs post-injection [44])) 438 from birth until weaning [45] . 439
Conclusions 440
We have shown for the first time that opioid receptor blockade induced by naloxone 441 administration immediately post weaning alters gene expression in the reward pathway in a 442 sex-specific manner, and that these effects are altered by perinatal junk food exposure. 443
Contrary to our initial hypothesis, however, opioid receptor blockade in the fourth week of 444 life did not have any long term effects on food preferences. These findings add to the growing 445 body of literature suggesting that the developing opioid and dopamine pathways are 446 susceptible to alteration by palatable food exposure during the perinatal period, but further 447 studies are required in order to determine whether alterations to the opioid signaling system 448 are the biological basis for the changes in food preferences observed. Better understanding the 449 mechanisms behind the programming of food preferences will be vital if we hope to design 450 interventions to prevent the cycle of obesity from mother to child from continuing. 451
